IM Cannabis Corp. SEC filings IMCC
IM Cannabis Corp. has 302 filings in SEC EDGAR's recent list, going back to Oct 24, 2019. Its latest annual report, Form 20-F, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-3 | Shelf registration (foreign issuer) | Oct 8, 2026 | — |
| 424B5 | Prospectus supplement | Sep 24, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 9, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Feb 5, 2026 | — |
| F-3/A | Filing | Aug 25, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 13, 2025 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 26, 2025 | — |
| F-10/A | Form f-10/a | Mar 31, 2021 | — |
| F-X | Form f-x | Mar 15, 2021 | — |
| F-10 | Form f-10 | Mar 15, 2021 | — |
| F-X | Form f-x | Feb 12, 2021 | — |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- IMCC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Central District, Israel
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1792030
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.